Table 1 The expression level of SNHG6 and clinic-pathological characteristics in 40 HCC patients
From: LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A
| SNHG6 Low | SNHG6 High | P-value | |
|---|---|---|---|
| All | 20 | 20 | |
| Sex | 0.744 | ||
| Male | 12 | 13 | |
| Female | 8 | 7 | |
| Age | 0.705 | ||
| ≤ 50 | 16 | 15 | |
| > 50 | 4 | 5 | |
| AFP(ng/ml) | 0.197 | ||
| ≤ 20 | 14 | 10 | |
| > 20 | 6 | 10 | |
| Tumor size (cm) | 0.337 | ||
| ≤ 5 | 10 | 13 | |
| > 5 | 10 | 7 | |
| Tumor numbers | 0.212 | ||
| Single | 18 | 15 | |
| Multiple | 2 | 5 | |
| Liver cirrhosis | 0.705 | ||
| Positive | 15 | 16 | |
| Negative | 5 | 4 | |
| Tumor nodes metastases stages | 0.043 | ||
| I | 16 | 9 | |
| II | 4 | 8 | |
| III | 0 | 3 | |